Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Accelerator-based Boron Neutron Capture Therapy (BNCT) in the Treatment of Locally Recurrent Head and Neck Carcinoma: A Phase I Study.

NCT07058116 is registered in ClinicalTrials.gov with Neutron Therapeutics, LLC as lead sponsor.

NCT NCT07058116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07058116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Accelerator-based Boron Neutron Capture Therapy (BNCT) in the Treatment of Locally Recurrent Head and Neck Carcinoma: A Phase I Study.
Lead sponsor
Neutron Therapeutics, LLC
Phase
Phase 1
Overall status
Recruiting
Start date
May 8, 2025
Completion date
January 30, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck carcinoma